Literature DB >> 21077750

Development of sponge-like dressings for mucosal/transmucosal drug delivery into vaginal cavity.

Silvia Rossi1, Marzia Marciello, Franca Ferrari, Antonella Puccio, Cristina Bonferoni, Giuseppina Sandri, Carla Caramella.   

Abstract

The aim of the present work was the development of vaginal sponge-like dressings based on chitosan ascorbate (CS) and on hyaluronic acid sodium salt/lysine acetate (HAS) combination. Sponge-like dressings were prepared by freeze-drying and characterized for mechanical resistance and mucoadhesion. CS dressings show higher mechanical and mucoadhesion properties in comparison with HAS dressing. The enzymatic inhibition properties of the dressings were evaluated in vitro against carboxipeptidase A in view of their employment for vaginal delivery of peptidic drugs. All the dressings were able to inhibit carboxipeptidase activity; CS dressings, independently of polymer MW, completely inhibited enzyme activity. Release and penetration enhancement properties of the dressings loaded with a high molecular weight hydrophilic molecule, fluorescein isothiocyanate dextran (FD4), were assessed. CS dressings were able to prolong FD4 release. All the dressings showed penetration enhancement properties into pig vaginal mucosa although to a different extent: greater for dressings based on CS than for that containing HAS. Moreover, CS dressings demonstrated intrinsic antimicrobial properties. The suitability of sponge-like systems for the treatment of vaginal infections was assessed by loading the CS dressing characterized by the best mechanical and antimicrobial properties with an antibiotic drug (clyndamicin-2-phosphate) and by checking drug release.
© 2012 Informa Healthcare USA, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21077750     DOI: 10.3109/10837450.2010.531736

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  1 in total

1.  Chitosan Ascorbate Nanoparticles for the Vaginal Delivery of Antibiotic Drugs in Atrophic Vaginitis.

Authors:  Silvia Rossi; Barbara Vigani; Antonella Puccio; Maria Cristina Bonferoni; Giuseppina Sandri; Franca Ferrari
Journal:  Mar Drugs       Date:  2017-10-19       Impact factor: 5.118

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.